284 related articles for article (PubMed ID: 14757682)
1. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Kimmelstiel CD; Maron BJ
Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
[No Abstract] [Full Text] [Related]
2. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
[No Abstract] [Full Text] [Related]
3. Hypertrophic obstructive cardiomyopathy and septal ablation.
Steinbis S
Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780
[No Abstract] [Full Text] [Related]
4. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Faber L
Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
[TBL] [Abstract][Full Text] [Related]
5. Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Chen SL; Ye F; Xu ZL; Lin S; Duan BX; Dai ZL; Shan SJ; Zhang JJ
Chin Med J (Engl); 2006 Jul; 119(13):1121-4. PubMed ID: 16834933
[No Abstract] [Full Text] [Related]
6. New approach to septal ablation: glue (cyanoacrylate) septal ablation.
Oto A; Aytemir K; Deniz A
Catheter Cardiovasc Interv; 2007 Jun; 69(7):1021-5. PubMed ID: 17525960
[TBL] [Abstract][Full Text] [Related]
7. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
[TBL] [Abstract][Full Text] [Related]
8. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
9. A case of hypertrophic obstructive cardiomyopathy complicated by a single coronary artery treated by transcoronary septal ablation.
Hara H; Ishii K; Nakamura M
J Invasive Cardiol; 2006 May; 18(5):234-8. PubMed ID: 16670451
[No Abstract] [Full Text] [Related]
10. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
[TBL] [Abstract][Full Text] [Related]
11. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy.
Jiang TY; Wu XS; Lu Q; Meng X; Jia CQ; Zhang Y
Chin Med J (Engl); 2004 Feb; 117(2):296-8. PubMed ID: 14975219
[No Abstract] [Full Text] [Related]
12. Percutaneous transluminal septal myocardial ablation performed via the right coronary artery rather than the left anterior descending artery for the treatment of hypertrophic obstructive cardiomyopathy.
Takagi K; Mukawa H; Morishima I; Uesugi M; Okumura Y; Tsuboi H; Sone T
Int J Cardiol; 2013 Jan; 162(3):e51-2. PubMed ID: 22981456
[No Abstract] [Full Text] [Related]
13. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
Veselka J
Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
[TBL] [Abstract][Full Text] [Related]
14. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
[TBL] [Abstract][Full Text] [Related]
15. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
Lawrenz T; Kuhn H
Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
[TBL] [Abstract][Full Text] [Related]
16. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.
Cheng TO
Circulation; 2004 Jul; 110(3):e23; author reply e23. PubMed ID: 15262858
[No Abstract] [Full Text] [Related]
17. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome.
Singh H; Kalra R; Keshavamurthy GB; Singh M; Singh C
Congenit Heart Dis; 2008; 3(5):347-51. PubMed ID: 18837814
[TBL] [Abstract][Full Text] [Related]
18. [Clinical case of the month. Treatment of obstructive hypertrophic cardiomyopathy by percutaneous septal ablation].
Hoffer E; Boland J
Rev Med Liege; 2002 Jul; 57(7):433-7. PubMed ID: 12233217
[TBL] [Abstract][Full Text] [Related]
19. Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient.
Höblinger A; Tiemann K; Nickenig G; Sauerbruch T; Lammert F
Z Gastroenterol; 2008 Oct; 46(10):1194-7. PubMed ID: 18937189
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Senaratne V; Sathanandan S; Ekanayake RA
Ceylon Med J; 2003 Sep; 48(3):92-3. PubMed ID: 14735809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
